Civic Intelligence

Altius Institute for Biomedical Sciences

990 • Fiscal year 2019 • EIN 47-2231080

Jan 01, 2019 to Dec 31, 2019 • Filed on Nov 16, 2020

2211 Elliott Avenue No 410Seattle, WA 98121

(206) 267-1091

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

76th percentile

0.55x

Higher debt load relative to assets than 76% of similar nonprofits.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2019

Liabilities / Revenue

71st percentile

0.58x

Higher debt load relative to revenue than 71% of similar nonprofits.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2019

Net Margin

10th percentile

-23%

Higher net margin than 10% of similar nonprofits.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2019

Top Officer Pay

95th percentile

$758,032

Higher top officer pay than 95% of similar nonprofits.

Top officer pay equals 4.5% of source-year revenue.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2019

Asset Growth

9th percentile

-8.9%

Faster asset growth than 9% of similar nonprofits.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2018 to 2019

Revenue Growth

13th percentile

-21%

Faster revenue growth than 13% of similar nonprofits.

2019 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2018 to 2019

Assets

Down

$17,764,328

Down $1,732,994 (-8.9%) from 2018

Net Assets

Down

$7,985,656

Down $3,859,962 (-33%) from 2018

Liabilities

Up

$9,778,672

Up $2,126,968 (+28%) from 2018

Revenue

Down

$16,965,373

Down $4,503,904 (-21%) from 2018

Expenses

Down

$20,825,335

Down $2,533,110 (-11%) from 2018

Net Income

Down

-$3,859,962

Down $1,970,794 (-104%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$80M$60M$40M$20M$0Assets 2016: $21,682,398Liabilities 2016: $8,902,692Net Assets 2016: $12,779,7062016Assets 2017: $26,358,989Liabilities 2017: $12,624,203Net Assets 2017: $13,734,7862017Assets 2018: $19,497,322Liabilities 2018: $7,651,704Net Assets 2018: $11,845,6182018Assets 2019: $17,764,328Liabilities 2019: $9,778,672Net Assets 2019: $7,985,6562019Assets 2020: $20,723,085Liabilities 2020: $8,197,072Net Assets 2020: $12,526,0132020Assets 2021: $61,078,390Liabilities 2021: $37,458,008Net Assets 2021: $23,620,3822021Assets 2022: $39,729,559Liabilities 2022: $13,226,158Net Assets 2022: $26,503,4012022Assets 2024: $17,386,206Liabilities 2024: $7,754,901Net Assets 2024: $9,631,3052024

Highlighted filing

2019

Assets$17,764,328
Liabilities$9,778,672
Net Assets$7,985,656

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MRevenue 2016: $27,959,116Expenses 2016: $20,271,920Net Income 2016: $7,687,1962016Revenue 2017: $22,821,561Expenses 2017: $21,866,481Net Income 2017: $955,0802017Revenue 2018: $21,469,277Expenses 2018: $23,358,445Net Income 2018: -$1,889,1682018Revenue 2019: $16,965,373Expenses 2019: $20,825,335Net Income 2019: -$3,859,9622019Revenue 2020: $25,217,625Expenses 2020: $22,201,302Net Income 2020: $3,016,3232020Revenue 2021: $44,158,765Expenses 2021: $33,064,396Net Income 2021: $11,094,3692021Revenue 2022: $55,346,565Expenses 2022: $54,165,332Net Income 2022: $1,181,2332022Revenue 2024: $25,521,018Expenses 2024: $32,275,657Net Income 2024: -$6,754,6392024

Highlighted filing

2019

Revenue$16,965,373
Expenses$20,825,335
Net Income-$3,859,962
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Nov 16, 2020
Return Version
2019v5.1
Gross Receipts
$16,965,373
Mission and Program Overview

Mission

The mission of the altius institute for biomedical sciences (altius) is to radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. To achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. Altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.

To radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. To achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. Altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$11,331,858$9,419,881▼ $1,911,977
Cash and Non-Interest-Bearing Accounts$1,010,997$4,228,856▲ $3,217,859
Savings and Temporary Cash Investments$2,091,249$3,795,513▲ $1,704,264
Prepaid Expenses and Deferred Charges$348,788$247,646▼ $101,142
Loans From Officers Directors$100,000$32,290▼ $67,710
Intangible Assets$23,725$23,725→ $0
Accounts Receivable$4,677,505$22,146▼ $4,655,359
Total Assets$19,497,322$17,764,328▼ $1,732,994
Other Assets Total$13,200$26,561▲ $13,361
Liabilities
Deferred Revenue$504,757$5,991,669▲ $5,486,912
Accounts Payable and Accrued Expenses$4,875,811$2,935,958▼ $1,939,853
Mortgage Notes Payable Secured by Investment Property$1,071,136$0▼ $1,071,136
Other Liabilities$1,100,000$818,755▼ $281,245
Total Liabilities$7,651,704$9,778,672▲ $2,126,968
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$11,845,618$7,985,656▼ $3,859,962
Total Net Assets Fund Balance$11,845,618$7,985,656▼ $3,859,962
Total Liabilities and Net Assets / Fund Balance$19,497,322$17,764,328▼ $1,732,994

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$1,678,502$7,207,917$8,886,419
Leasehold Improvements$6,716,919$2,084,162$8,801,081
Other Land Buildings$1,024,460$94,895$1,119,355
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
John StamatoyannopoulosPresident/scientific DirectorFT$715,500$42,532$758,032
Michael CockrilChief Technology OfficerFT$285,124$62,129$347,253
Allister FunnellDeputy DirectorFT$227,500$41,805$269,305
Jeff VierstraPrincipal InvestigatorFT$194,860$46,334$241,194
Wouter MeulemanPrincipal InvestigatorFT$185,228$50,907$236,135
Tim MercerPrincipal InvestigatorFT$170,726$24,706$195,432
Lori Tonnes-priddySecretaryPT$71,205-$71,205
Peter HandrinosBoard Member-$15,000-$15,000
Hal DietzBoard Member-$15,000-$15,000

Board Members and Trustees

NameTitle
Tony WoodBoard Member

Highest Paid Contractors

ContractorServicesLocationCompensation
Keith GrochowSoftware Development1425 BROADWAY, Seattle, WA 98122$108,750
Revenue and Support

Revenue Composition

Contributions and Grants
$16,956,091
Program Service Revenue
$0
Investment Income
$9,282
Other Revenue
$0
All Other Contributions
$11,723,771
Change in Net Assets
$-3,859,962
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$10,893,763
Other Expenses$9,842,688
Grants and Similar Amounts Paid$88,884
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$6,637,721$1,370,981-$8,008,702
Depreciation Depletion$1,780,174$173,385-$1,953,559
Other Employee Benefits$1,310,810$75,472-$1,386,282
Occupancy$1,219,803$144,564-$1,364,367
Information Technology$899,666$224,917-$1,124,583
Current Officers, Directors, Trustees, and Key Employees$758,032$101,205-$859,237
Fees for Services Other$20,160$648,001-$668,161
Payroll Taxes$543,611$95,931-$639,542
Travel$267,657$14,087-$281,744
Office Expenses$128,135$64,056-$192,191
Other Expenses$282,869$94,195-$94,195
Foreign Grants$88,884--$88,884
Conferences and Meetings$74,180$3,904-$78,084
Insurance-$77,301-$77,301
Interest-$67,880-$67,880
All Other Expenses-$39,310-$39,310
Total Functional Expenses$17,630,146$3,195,189$0$20,825,335
International Activity

International Summary

Offices
0
Employees
0
Spending
$88,884

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumGrants to Recipients Located in the Region-00$88,884
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumFundraising-00-
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Tonnes Pllc35%+ OWNED ENTITY OF LORI TONNES-PRIDDY, OFFICER OF THE ORGANIZATIONLegal ServicesNo$71,205

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$100,000$32,290▼ $67,710
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Lease Incentive Obligation, Net$633,778
Deferred Rent$184,977
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
Yes
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

The organization has one class of membership which includes two members, dr. John stamatoyannopoulos (or his designee) and glaxosmithkline llc.

Form 990, Part VI, Section A, Line 7A

The members of the organization are entitled to elect directors of the board and remove only directors which they have appointed.

Form 990, Part VI, Section A, Line 7B

The glaxosmithkline llc member may elect and remove glaxosmithkline llc directors of the board while john stamatoyannopoulos as a member may elect and remove john stamatoyannopoulos directors of the board. Common directors of the board are elected and removed by unanimous action of john stamatoyannopoulos and glaxosmithkline llc members.

Form 990, Part VI, Section B, Line 11B

The president/scientific director, audit committee, and general counsel will review the form 990 prior to its submission to the irs.

Form 990, Part VI, Section B, Line 12C

The organization's conflict of interest policy requires covered persons, defined as any director, officer, or member of a committee of the board of directors, to complete and sign an annual conflict of interest questionnaire. The questionnaire requires disclosure of any potential or actual conflicts of interest and is signed by the covered person, affirming that the individual has received a copy of, read, understands, and will comply with the organization's conflict of interest policy. If a potential or actual conflict of interest arises, the individual must recuse himself or herself from voting on the matter and must not be present when any such vote is taken. The board of directors evaluates all disclosures reported to determine whether an actual conflict of interest exists. Potential or actual conflicts of interest are documented in the minutes of meetings of the board of directors and committee's of the board.

Form 990, Part VI, Section B, Line 15

A compensation study was conducted by an outside consultant in 2019 to determine the compensation for the president and cto. The compensation study was approved by the board of directors. The study is effective through 2020. The next study is in the process of being compiled.

Form 990, Part VI, Section C, Line 19

The governing documents, conflict of interest policy and financial statements are made available to the public upon request.

Filing and Contact Details

Filer

Filer Name
Altius Institute for Biomedical Sciences
EIN
47-2231080
Phone
2062671091
Address
2211 ELLIOTT AVENUE NO 410, SEATTLE, WA 98121

Signing Officer

Name
John Stamatoyannopoulos
Title
President/scientific Director
Phone
2062671091
Signed
2020-11-16
Discuss with paid preparer
Yes

Organization Details

Principal Officer
John Stamatoyannopoulos
Formed
2014
Legal Domicile
De
Voting Board Members
4
Independent Board Members
3
Employees
89
Volunteers
1

Preparer

Firm
Clark Nuber Ps
Address
10900 NE 4TH STREET SUITE 1400, BELLEVUE, WA 98004
Preparer
Sara Elizabeth J Hyre
Phone
4254544919
Supplemental Narrative

Additional Explanations

PART IX, FUNCTIONAL EXPENSE ALLOCATION:

All expenses associated with obtaining grants are included in program and general and administrative expenses as allowed under the indirect cost recovery provisions of the grant agreement.

PART XII, LINE 2B:

The organization's financial statement audit has not been finalized at the time of the tax return filing.

Raw XML AppendixShowing 400 of 620 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt04875811
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02935958
IRS990/AccountsReceivableGrp/BOYAmt04677505
IRS990/AccountsReceivableGrp/EOYAmt022146
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
IRS990/AllOtherContributionsAmt011723771
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt039310
IRS990/AllOtherExpensesGrp/TotalAmt039310
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/PersonNm0LISA JENNESS
IRS990/BooksInCareOfDetail/PhoneNum02062671091
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02211 ELLIOTT AVENUE SUITE 410
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098121
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd01
IRS990/CashNonInterestBearingGrp/BOYAmt01010997
IRS990/CashNonInterestBearingGrp/EOYAmt04228856
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0101205
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0758032
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0859237
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt03904
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt074180
IRS990/ConferencesMeetingsGrp/TotalAmt078084
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0108750
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01425 BROADWAY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0SEATTLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0WA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd098122
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0KEITH GROCHOW
IRS990/ContractorCompensationGrp/ServicesDesc0SOFTWARE DEVELOPMENT
IRS990/ContractTerminationInd0X
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt016956091
IRS990/CYGrantsAndSimilarPaidAmt088884
IRS990/CYInvestmentIncomeAmt09282
IRS990/CYOtherExpensesAmt09842688
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-3859962
IRS990/CYSalariesCompEmpBnftPaidAmt010893763
IRS990/CYTotalExpensesAmt020825335
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt016965373
IRS990/DecisionsSubjectToApprovaInd01
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0504757
IRS990/DeferredRevenueGrp/EOYAmt05991669
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0173385
IRS990/DepreciationDepletionGrp/ProgramServicesAmt01780174
IRS990/DepreciationDepletionGrp/TotalAmt01953559
IRS990/Desc0ALTIUS DIRECTLY CONDUCTS AN ACTIVE AND MULTIFACETED PROGRAM OF BIOTECHNOLOGY RESEARCH. WE CONDUCT A CONSIDERABLE MAJORITY OF RESEARCH PROGRAMS DIRECTLY IN OUR OWN RESEARCH LABORATORY FACILITY, LOCATED IN SEATTLE. THE MEDICAL RESEARCH ORGANIZATION PROGRAM IS INTENDED TO GENERATE, DEVELOP AND TRANSLATE TO CLINICAL USE REGULATORY GENOMIC AND OTHER TECHNOLOGIES THAT HAVE TRANSFORMATIVE POTENTIAL IN BASIC BIOLOGY, BIOMEDICINE AND PHARMACEUTICAL DEVELOPMENT AND VALIDATION. INITIAL EFFORTS OF OUR RESEARCH PROGRAM FOCUS ON DEVELOPING A RICHER UNDERSTANDING OF HUMAN CELL MODELS, TARGETS AND MECHANISMS, FOR THE PURPOSE OF DEVELOPING NEW THERAPIES FOR DISEASE. TO THIS END, THE ORGANIZATION WILL FOCUS DEVELOPMENT ON DRIVING THE SCALING AND TRANSLATIONAL VALIDATION OF EXISTING CUTTING EDGE RESEARCH PLATFORMS, INCLUDING REGULATORY GENOMIC ANALYSES AND GENOME ENGINEERING TECHNOLOGIES. REGULATORY GENOMIC ANALYSIS YIELDS A HIGH-CONTENT, QUANTITATIVE ASSESSMENT OF INDIVIDUAL REGULATORY ELEMENTS, WHICH PROVIDES HIGHLY SENSITIVE MARKERS OF CELLULAR RESPONSE TO DISEASE AND TO CURRENT AND PAST DRUG EXPOSURES. SUCH ASSESSMENTS INFORM WHAT TISSUE AND TARGET TO STUDY, HOW TO MODULATE A DRUG TARGET, ANTICIPATE OFF-TARGET EFFECTS, AND PROTOTYPE DRUG TREATMENT EFFECTS.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt089
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt017630146
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditPerformedInd01
IRS990/FederalGrantAuditRequiredInd01
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0648001
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt020160
IRS990/FeesForServicesOtherGrp/TotalAmt0668161
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt088884
IRS990/ForeignGrantsGrp/TotalAmt088884
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt65.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt82.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.50
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt042532
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt162128
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt241805
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt346333
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt450907
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt524707
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN STAMATOYANNOPOULOS
IRS990/Form990PartVIISectionAGrp/PersonNm1MICHAEL COCKRIL
IRS990/Form990PartVIISectionAGrp/PersonNm2ALLISTER FUNNELL
IRS990/Form990PartVIISectionAGrp/PersonNm3JEFF VIERSTRA
IRS990/Form990PartVIISectionAGrp/PersonNm4WOUTER MEULEMAN
IRS990/Form990PartVIISectionAGrp/PersonNm5TIM MERCER
IRS990/Form990PartVIISectionAGrp/PersonNm6LORI TONNES-PRIDDY
IRS990/Form990PartVIISectionAGrp/PersonNm7HAL DIETZ
IRS990/Form990PartVIISectionAGrp/PersonNm8PETER HANDRINOS
IRS990/Form990PartVIISectionAGrp/PersonNm9TONY WOOD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0715500
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1285124
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt2227500
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3194860
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4185228
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5170726
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt671205
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt715000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt815000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT/SCIENTIFIC DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1CHIEF TECHNOLOGY OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt2DEPUTY DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3PRINCIPAL INVESTIGATOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4PRINCIPAL INVESTIGATOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5PRINCIPAL INVESTIGATOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt7BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt8BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt9BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/OtherAmt0991
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GovernmentGrantsAmt05232320
IRS990/GrantAmt088884
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/OtherAmt0991
IRS990/GrossReceiptsAmt016965373
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0224917
IRS990/InformationTechnologyGrp/ProgramServicesAmt0899666
IRS990/InformationTechnologyGrp/TotalAmt01124583
IRS990/InsuranceGrp/ManagementAndGeneralAmt077301
IRS990/InsuranceGrp/TotalAmt077301
IRS990/IntangibleAssetsGrp/BOYAmt023725
IRS990/IntangibleAssetsGrp/EOYAmt023725
IRS990/InterestGrp/ManagementAndGeneralAmt067880
IRS990/InterestGrp/TotalAmt067880
IRS990/InvestmentIncomeGrp/ExclusionAmt08291
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt08291
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt024
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt09386974
IRS990/LandBldgEquipBasisNetGrp/BOYAmt011331858
IRS990/LandBldgEquipBasisNetGrp/EOYAmt09419881
IRS990/LandBldgEquipCostOrOtherBssAmt018806855
IRS990/LegalDomicileStateCd0DE
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt00
IRS990/LoanOutstandingInd01
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0100000
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt032290
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES (ALTIUS) IS TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/MortgNotesPyblScrdInvstPropGrp/BOYAmt01071136
IRS990/MortgNotesPyblScrdInvstPropGrp/EOYAmt00
IRS990/NetAssetsOrFundBalancesBOYAmt011845618
IRS990/NetAssetsOrFundBalancesEOYAmt07985656
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0991
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0991
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt011845618
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt07985656
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0144564
IRS990/OccupancyGrp/ProgramServicesAmt01219803
IRS990/OccupancyGrp/TotalAmt01364367
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt064056
IRS990/OfficeExpensesGrp/ProgramServicesAmt0128135
IRS990/OfficeExpensesGrp/TotalAmt0192191
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt013200
IRS990/OtherAssetsTotalGrp/EOYAmt026561
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt075472
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt01310810
IRS990/OtherEmployeeBenefitsGrp/TotalAmt01386282
IRS990/OtherExpensesGrp/Desc0LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc1RESEARCH COLLABORATIONS
IRS990/OtherExpensesGrp/Desc2RESEARCH & DEVELOPMENT
IRS990/OtherExpensesGrp/Desc3BUSINESS TAX & LICENSES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt094195
IRS990/OtherExpensesGrp/ProgramServicesAmt02718602
IRS990/OtherExpensesGrp/ProgramServicesAmt1899842
IRS990/OtherExpensesGrp/ProgramServicesAmt2282869
IRS990/OtherExpensesGrp/TotalAmt02718602
IRS990/OtherExpensesGrp/TotalAmt1899842
IRS990/OtherExpensesGrp/TotalAmt2282869
IRS990/OtherExpensesGrp/TotalAmt394195
IRS990/OtherLiabilitiesGrp/BOYAmt01100000
IRS990/OtherLiabilitiesGrp/EOYAmt0818755
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt01370981
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt06637721
IRS990/OtherSalariesAndWagesGrp/TotalAmt08008702
IRS990/PartialLiquidationInd01
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt095931
IRS990/PayrollTaxesGrp/ProgramServicesAmt0543611
IRS990/PayrollTaxesGrp/TotalAmt0639542
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0348788
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0247646
IRS990/PrincipalOfficerNm0JOHN STAMATOYANNOPOULOS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt021464371
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0106164
IRS990/PYInvestmentIncomeAmt04906
IRS990/PYOtherExpensesAmt011674185
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-1889168
IRS990/PYSalariesCompEmpBnftPaidAmt011578096
IRS990/PYTotalExpensesAmt023358445
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt021469277
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-3859962
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt02091249
IRS990/SavingsAndTempCashInvstGrp/EOYAmt03795513
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0BOSTON
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm1NEW HAVEN
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0MA
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd1CT
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0BRIGHAM AND WOMEN'S HOSPITAL
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt1YALE SCHOOL OF MEDICINE
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt01678502
IRS990ScheduleD/EquipmentGrp/DepreciationAmt07207917
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt08886419
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt06716919
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt02084162
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt08801081
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt01024460
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt094895
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt01119355
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0184977
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt1633778
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0DEFERRED RENT
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1LEASE INCENTIVE OBLIGATION, NET
IRS990ScheduleD/TotalBookValueLandBuildingsAmt09419881
IRS990ScheduleD/TotalLiabilityAmt0818755
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt088884
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0GRANTS TO RECIPIENTS LOCATED IN THE REGION
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1FUNDRAISING
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt088884
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0SUBCONTRACT ON CEGS NIH GRANT
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0EUROPE(INCLUDING ICELAND AND GREENLAND)
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt088884
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0LUDWIG MAXIMILIANS-UNIVERSITAT (LMU) IS A SUB-RECIPIENT OF THE NATIONAL INSTITUTE OF HEALTH GRANT FOR CEGS. THEY WERE ONBOARDED AND ARE MONITORED LIKE OUR OTHER SUB-RECIPIENTS IN THE UNITED STATES. ALTIUS HAS A PROCEDURE THAT CONFORMS WITH THE UNIFORM GUIDANCE WHEN WE ENGAGE/ONBOARD/MONITOR SUB-RECIPIENTS. THE LEGAL CONTRACT TEAM ALSO REVIEWS THE SUB-RECIPIENT AWARD AND ASKS PERTINENT QUESTIONS.
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt1THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON THE ACCRUAL BASIS OF ACCOUNTING.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1PART III ACCOUNTING METHOD:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc2PART I, LINE 3:
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalOtherOrgCnt00
IRS990ScheduleF/TotalSpentAmt088884
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/CompensationCommitteeInd0X
IRS990ScheduleJ/CompensationSurveyInd0X
IRS990ScheduleJ/DiscretionarySpendingAcctInd0X
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/FirstClassOrCharterTravelInd0X
IRS990ScheduleJ/Form990OfOtherOrganizationsInd0X
IRS990ScheduleJ/IndependentConsultantInd0X
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0715500
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt1285124
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt2227500
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt3194860
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt4185228
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt5170726
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount20
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount30
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount40
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount50
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt20

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2019 filings • 501(c)3 • $10M-$25M nonprofits